Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis - In-TARGET
Clinical trial NCT02425865 · COMPLETED
Trial details
- NCT number
- NCT02425865
- Sponsor
- Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2021-10-01
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.